{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:46:53Z","timestamp":1773294413827,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1097\/wnf.0000000000000064","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T05:48:11Z","timestamp":1421041691000},"page":"30-35","source":"Crossref","is-referenced-by-count":5,"title":["The Relationship Between Symptomatic and Functional Changes of Korean Children and Adolescents With Attention-Deficit\/Hyperactivity Disorder Treated With Osmotic-Controlled Release Oral Delivery System\u2013Methylphenidate"],"prefix":"10.1097","volume":"38","author":[{"given":"Eunjoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun-Ah","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Sook","family":"Joung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"2","key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00787-009-0046-3","article-title":"The quality of life of children with attention deficithyperactivity disorder: a systematic review.","volume":"19","author":"Danckaerts","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1469-7610.1995.tb02320.x","article-title":"Adaptive skills dysfunction in ADD and ADHD children.","volume":"36","author":"Stein","year":"1995","journal-title":"J Child Psychol Psychiatry"},{"issue":"2","key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004583-199902000-00011","article-title":"Impaired but undiagnosed.","volume":"38","author":"Angold","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1087054709332460","article-title":"Life impairments in adults with medication-treated ADHD.","volume":"13","author":"Safren","year":"2009","journal-title":"J Atten Disord"},{"issue":"suppl 12","key":"R5-7-20210203","first-page":"23","article-title":"Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.","volume":"63","author":"Saylor","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4088\/JCP.08m04709pur","article-title":"Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficithyperactivity disorder.","volume":"71","author":"Weiss","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/cap.2008.0166","article-title":"Atomoxetine and neuropsychological function in children with attention-deficithyperactivity disorder: results of a pilot study.","volume":"19","author":"Maziade","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0009922806294219","article-title":"Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning.","volume":"45","author":"Brown","year":"2006","journal-title":"Clin Pediatr (Phila)"},{"issue":"3","key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1469-7610.2008.01960.x","article-title":"Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo.","volume":"50","author":"Buitelaar","year":"2009","journal-title":"J Child Psychol Psychiatry"},{"issue":"6","key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","article-title":"Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.","volume":"165","author":"Newcorn","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"6","key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/cap.2008.074","article-title":"Atomoxetine treatment in adolescents with attention-deficithyperactivity disorder.","volume":"19","author":"Wietecha","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3349\/ymj.2004.45.1.81","article-title":"The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean version (K-SADS-PL-K).","volume":"45","author":"Kim","year":"2004","journal-title":"Yonsei Med J"},{"key":"R15-7-20210203","first-page":"283","article-title":"The reliability and validity of Korean parent and teacher ADHD rating scale.","volume":"41","author":"So","year":"2002","journal-title":"J Korean Neuropsychiatr Assoc"},{"issue":"6","key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/cap.2007.0030","article-title":"The Life Participation Scale for Attention-DeficitHyperactivity Disorder-Child Version: psychometric properties of an adaptive change instrument.","volume":"17","author":"Saylor","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4088\/JCP.08m04709pur","article-title":"Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficithyperactivity disorder.","volume":"71","author":"Weiss","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1087054705283881","article-title":"Symptoms versus impairment: the case for respecting DSM-IVs criterion D.","volume":"9","author":"Gordon","year":"2006","journal-title":"J Atten Disord"},{"issue":"5","key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1542\/peds.2004-0844","article-title":"Health-related quality of life in children and adolescents who have a diagnosis of attention-deficithyperactivity disorder.","volume":"114","author":"Klassen","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1037\/a0027347","article-title":"Validity of DSM-IV attention deficithyperactivity disorder symptom dimensions and subtypes.","volume":"121","author":"Willcutt","year":"2012","journal-title":"J Abnorm Psychol"},{"issue":"7","key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/DBP.0b013e3182a39890","article-title":"The relationship between ADHD symptom dimensions, clinical correlates, and functional impairments.","volume":"34","author":"Garner","year":"2013","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/108705470300700101","article-title":"A chart review study of the inattentive and combined types of ADHD.","volume":"7","author":"Weiss","year":"2003","journal-title":"J Atten Disord"},{"issue":"5","key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/cap.2007.0071","article-title":"Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-DeficitHyperactivity Disorder Treatment Study (PATS).","volume":"17","author":"Ghuman","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1087054709332460","article-title":"Life impairments in adults with medication-treated ADHD.","volume":"13","author":"Safren","year":"2010","journal-title":"J Atten Disord"},{"issue":"4","key":"R25-7-20210203","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004703-200408000-00006","article-title":"Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine.","volume":"25","author":"Perwien","year":"2004","journal-title":"J Dev Behav Pediatr"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:10:00Z","timestamp":1620976200000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201501000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000064","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}